Hims & Hers Health Under Investigation for Securities Fraud

The DJS Law Group has initiated an investigation into potential violations of securities laws on behalf of investors of Hims & Hers Health, Inc. (“Hims & Hers” or “the Company”) (NYSE: HIMS). The investigation is centered on whether the Company made misleading statements and/or failed to disclose important information to investors. Novo Nordisk, in a press release on June 23, 2025, revealed that it was ending its collaboration with Hims & Hers Health, Inc. due to concerns regarding their illegal mass compounding and deceptive marketing practices.

According to the press release, the FDA addressed the Wegovy shortage by determining that Novo Nordisk was meeting current and projected demand for the medicine nationwide. Novo Nordisk started collaborating with telehealth companies to help transition patients from compounded versions to FDA-approved Wegovy. However, Hims & Hers Health, Inc. failed to comply with the law prohibiting mass sales of compounded drugs under the pretext of ‘personalization’ and engaged in misleading marketing that jeopardized patient safety. Following this news, shares of Hims & Hers plummeted by 31.7% during afternoon trading on June 23, 2025.

If you are a shareholder who experienced losses, reach out to us for potential participation in the investigation. DJS Law Group stands out for its commitment to enhancing investor returns through sound guidance and assertive advocacy. We specialize in areas such as securities class actions, corporate governance litigation, and M&A appraisals, catering to some of the world’s most prominent hedge funds and alternative asset managers. The litigation claims managed by our firm are highly valuable assets that demand careful attention, focus, and outcomes.

This press release may qualify as Attorney Advertising in certain jurisdictions as per applicable laws and ethical guidelines. If you seek more information or wish to get in touch with us, you can reach out to David J. Schwartz at DJS Law Group.

In conclusion, the DJS Law Group is actively investigating potential securities law violations concerning Hims & Hers Health, Inc. It is imperative to ensure transparency and adherence to regulations in the financial sector to protect investors and maintain trust in the market.